TABLE 2.
Variable | Total population (n = 129) | No anxiety diagnosis (n = 62) | Anxiety diagnosis (n = 67) | Statistical test and sig. |
---|---|---|---|---|
Age, y (Mean, SD) | 17.4 (4.1) | 17.6 (4.4) | 17.1 (3.7) | t = 0.84, p = 0.40 |
Sex | X2 = 0.70, p = .40 | |||
Female, n | 38 | 17 | 21 | |
Male, n | 58 | 31 | 27 | |
Medication, n | 26 | 16 | 10 | X2 = 2.37, p = .12 |
Race, n | X2 = 4.46, p = .72 | |||
Asian | 5 | 1 | 4 | |
Black | 9 | 6 | 3 | |
Latinx | 16 | 7 | 9 | |
Middle Eastern | 1 | 1 | 0 | |
Multiracial | 5 | 2 | 3 | |
Native American | 2 | 1 | 1 | |
N/A | 42 | 19 | 23 | |
White | 49 | 25 | 24 | |
Education, y (Mean, SD) | 10.3 (2.7) | 10.3 (2.7) | 10.2 (2.7) | t = 0.17, p = 0.87 |
Comorbid Diagnoses, n | ||||
Mood disorder | 45 | 22 | 23 | X2 = 0.05, p = .83 |
Bipolar disorder | 6 | 3 | 3 | X2 = 0.01, p = .93 |
Substance use disorder | 8 | 6 | 2 | X2 = 2.81, p = .42 |
Obsessive compulsive disorder | 9 | - | 9 | |
Post-traumatic stress disorder | 3 | - | 3 | |
Panic disorder | 12 | - | 12 | |
Agoraphobia | 1 | - | 1 | |
Social anxiety | 12 | - | 12 | |
Specific anxiety | 16 | - | 16 | |
General anxiety | 30 | - | 30 | |
Somatoform disorder | 5 | - | 5 | |
Treatment, n | X2 = .65, p = .42 | |||
Family focused treatment group | 66 | 34 | 32 | |
Enhanced care treatment group | 63 | 28 | 35 |
Anxiety and no anxiety groups did not differ by descriptives.